Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study

This study is currently recruiting participants.
Verified April 2014 by University of Washington
Sponsor:
Information provided by (Responsible Party):
Elizabeth Swisher, University of Washington
ClinicalTrials.gov Identifier:
NCT01544049
First received: February 28, 2012
Last updated: April 8, 2014
Last verified: April 2014
  Purpose

The purpose of this study is to better understand why women choose to have their fallopian tubes removed as a method for ovarian cancer prevention. This will be done through a paper questionnaire and phone interviews. The investigators hope to gain information that will allow us to better counsel women about ovarian cancer prevention.


Condition
Ovarian Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Patients Salpingectomy as a Method of Ovarian Cancer Prevention: A Descriptive Study

Resource links provided by NLM:


Further study details as provided by University of Washington:

Primary Outcome Measures:
  • Describe subject experience in undergoing Salpingectomy as a means of riks reduction [ Time Frame: At conclusion of study ] [ Designated as safety issue: No ]
    Subjects will provide information on their reason for choosing salpingectomy and the process they went through in undergoing this procedure


Estimated Enrollment: 25
Study Start Date: December 2011
Estimated Study Completion Date: August 2014
Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Fallopian tube removal
Women who have had one or both fallopian tube(s) removed as method of ovarian cancer prevention.

Detailed Description:

Women will be found eligible for this study after an eligibility questionnaire given over the phone. If one is found eligible, she will be sent a consent and paper survey to fill out and send back to the research coordinator. Once that is completed, she will be given a phone interview in order answer additional questions of interest. Lastly, the study participant will be contacted once a year over the phone to obtain follow-up information.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Women who have had their fallopian tubes removed as a method of ovarian cancer prevention.

Criteria

Inclusion Criteria:

  • Female of at least 18 years of age
  • Must speak English fluently
  • Have had fallopian tubes removed as a method of ovarian cancer prevention

Exclusion Criteria:

  • Males
  • Females under the age of 18
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01544049

Contacts
Contact: Kathy J Agnew, BS 206-685-7927 kagnew@uw.edu

Locations
United States, Washington
University of Washington Recruiting
Seattle, Washington, United States, 98195
Contact: Kathy J Agnew, BS    206-685-7927    kagnew@uw.edu   
Principal Investigator: Elizabeth Swisher, MD         
Sponsors and Collaborators
University of Washington
Investigators
Principal Investigator: Elizabeth Swisher, MD University of Washington
  More Information

No publications provided

Responsible Party: Elizabeth Swisher, Professor, University of Washington
ClinicalTrials.gov Identifier: NCT01544049     History of Changes
Other Study ID Numbers: 41774-G
Study First Received: February 28, 2012
Last Updated: April 8, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by University of Washington:
fallopian tube removal
salpingectomy
ovarian cancer prevention

Additional relevant MeSH terms:
Ovarian Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Urogenital Neoplasms
Endocrine System Diseases
Gonadal Disorders

ClinicalTrials.gov processed this record on April 17, 2014